Renal dysfunction after orthotopic heart transplantation:: Incidence, natural history, and risk factors

被引:12
作者
Garrido, IP
Crespo-Leiro, MG
Paniagua, MJ
Muñiz, J
Rodríguez, JA
Regueiro, M
Vázquez-Rey, E
Cuenca-Castillo, JJ
Castro-Beiras, A
机构
[1] Juan Canalejo Univ, Hosp Complex, La Coruna, Spain
[2] Univ A Coruna, Inst Hlth Sci, La Coruna, Spain
关键词
D O I
10.1016/S0041-1345(03)00662-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background. Renal dysfunction is a common complication after orthotopic heart transplantation (FIT). The importance of factors other than exposure to immunosuppressive drugs is unclear. The purpose of this study was to determine the incidence and natural history of renal dysfunction following heart transplantation, and to evaluate a number of variables as risk factors for this condition. Methods. We examined the creatinine levels at 1, 6, 12, 24, and 60 months in 262 consecutive heart transplant patients who survived at least 1 year. The potential risk factors included pre- and posttransplantation diabetes mellitus, arterial hypertension, and drugs used to control arterial hypertension. Results. 17.2% of patients showed mild renal dysfunction (creatinine 1.5-2.5 mg/dL) and 1.9% moderate dysfunction (creatinine >2.5 mg/dL) at 1 month; 29.8% showed mild and 1.1% moderate dysfunction at 6 months; 33.2% showed mild and 1.9% moderate dysfunction at 1 year; 40% showed mild, 0.9% moderate and 0.4% severe dysfunction (requiring dialysis or renal transplantation) at 2 years; and 43.6% showed mild, 1.7% moderate and 0.9% severe dysfunction at 5 years. None of the conditions analyzed as possible risk factors showed a significant association with renal dysfunction except the use of diuretics. Conclusion. The incidence of renal dysfunction after orthotopic heart transplantation was 33.6% within the first year after transplant and 44% within the first five years, although more than 95% of cases were mild. The incidence increased with time after transplantation. Renal dysfunction seems likely to be multifactorial in origin, but no individual risk factors were identified.
引用
收藏
页码:2014 / 2016
页数:3
相关论文
共 12 条
[1]
NATURE AND EXTENT OF GLOMERULAR INJURY INDUCED BY CYCLOSPORINE IN HEART-TRANSPLANT PATIENTS [J].
BERTANI, T ;
FERRAZZI, P ;
SCHIEPPATI, A ;
RUGGENENTI, P ;
GAMBA, A ;
PARENZAN, L ;
MECCA, G ;
PERICO, N ;
IMBERTI, O ;
REMUZZI, A ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1991, 40 (02) :243-250
[2]
Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients:: Safety and efficacy [J].
Crespo-Leiro, MG ;
Paniagua, MJ ;
Mosquera, I ;
Tabuyo, T ;
De la Fuente, L ;
Bouzas, B ;
Rodriguez, JA ;
Hermida, LF ;
Juffé, A ;
Castro-Beiras, A .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) :113-114
[3]
Risk factors for chronic renal dysfunction in cardiac allograft recipients [J].
Esposito, C ;
Semeraro, L ;
Bellotti, N ;
Fasoli, G ;
Fornoni, A ;
Rampino, T ;
Klersy, C ;
Campana, C ;
Gavazzi, A ;
Viganò, M ;
Dal Canton, A .
NEPHRON, 2000, 84 (01) :21-28
[4]
Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine [J].
Falkenhain, ME ;
Cosio, FG ;
Sedmak, DD .
TRANSPLANTATION, 1996, 62 (03) :364-370
[5]
GOLDSTEIN DJ, 1997, TRANSPLANTATION, V63, P644
[6]
CYCLOSPORINE NEPHROTOXICITY IN CARDIAC ALLOGRAFT PATIENTS - A 7-YEAR FOLLOW-UP [J].
GREENBERG, A ;
THOMPSON, ME ;
GRIFFITH, BJ ;
HARDESTY, RL ;
KORMOS, RL ;
ELSHAHAWY, MA ;
JANOSKY, JE ;
PUSCHETT, JB .
TRANSPLANTATION, 1990, 50 (04) :589-593
[7]
Risks and costs of end-stage renal disease after heart transplantation [J].
Hornberger, J ;
Best, J ;
Geppert, J ;
McClellan, M .
TRANSPLANTATION, 1998, 66 (12) :1763-1770
[8]
Predictors of renal function following lung or heart-lung transplantation [J].
Ishani, A ;
Erturk, S ;
Hertz, MI ;
Matas, AJ ;
Savik, K ;
Rosenberg, ME .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2228-2234
[9]
CYCLOSPORINE-ASSOCIATED CHRONIC NEPHROPATHY [J].
MYERS, BD ;
ROSS, J ;
NEWTON, L ;
LUETSCHER, J ;
PERLROTH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (11) :699-705
[10]
THE LONG-TERM COURSE OF CYCLOSPORINE-ASSOCIATED CHRONIC NEPHROPATHY [J].
MYERS, BD ;
SIBLEY, R ;
NEWTON, L ;
TOMLANOVICH, SJ ;
BOSHKOS, C ;
STINSON, E ;
LUETSCHER, JA ;
WHITNEY, DJ ;
KRASNY, D ;
COPLON, NS ;
PERLROTH, MG .
KIDNEY INTERNATIONAL, 1988, 33 (02) :590-600